Moreover, IV-induced regeneration failure could be counteracted by intratracheal application of excess recombinant Fgf10, suggesting recruitment of the non-infected Fgfr2bhigh stem cell fraction for repair as putative novel treatment strategy to drive organ regeneration in patients with IV-induced ARDS. This evidence concerns the gene FGF10 and acute respiratory distress syndrome.